This short training video is intended for women who have made the decision to self-inject subcutaneous DMPA (DMPA-SC) in the context of informed choice counseling. DMPA-SC is a lower-dose, easy-to-use injectable contraceptive that is administered every three months. The product’s user-friendly design means that any trained person can administer it, including community health workers, pharmacists, and even women themselves.
DMPA-SC is an all-in-one injectable contraceptive that combines the drug and needle in the Uniject™ injection system. DMPA-SC is a low dose formulation of progestin-only contraceptive and contains 104mg of DMPA per 0.65ml dose. DMPA-SC is administered via subcutaneous injection (similar to insulin injections) and lasts three (3) months.
The purpose of this activity was to generate experience from a DMPA-SC self-injection pilot in the private sector to inform country and global learning, and to provide the Zambian MOH with operational recommendations for policy and program planning.
At the London Family Planning Summit in 2012, the Government of Uganda committed to providing universal access to family planning and reducing unmet need for family planning from the current 40 percent to 10 percent by 2022. To meet this ambitious goal, all potential means of increasing accessibility to family planning must be explored.
This brief outlines the background, objectives, implementation steps & timeline, overview, and indicators of APC Benin’s community-based access to injectable contraceptives pilot project.
This brief outlines the background, objectives, implementation steps & timeline, overview, and indicators of APC Benin’s community-based access to injectable contraceptives pilot project.
This brief outlines the details of a study requested by the Malawi Ministry of Health and USAID/Malawi to assess home and self-injection of Sayana® Press in Malawi.
These resources are intended to be used by advocates, program managers, policymakers, donors, ministry of health staff, and other key stakeholders to craft a strategy for building support for CBA2I among key decision makers in country. Because community-based access to injectable contraceptives (CBA2I) has the potential to significantly expand access to and use of modern contraceptive methods, several countries are employing CBA2I strategies to help achieve their FP2020 goals.
This brief provides guidance on writing policy to enable the provision of injectable contraceptives by non-clinical community health workers (CHWs) and is intended for use by policymakers and influencers who are interested in changing national policy to support the provision of injectable contraceptives by CHWs.
This brief focuses on the use of drug shops to increase access to injectable contraceptives, a strategy that had previously not received sufficient attention in the literature.
This short training video is intended for women who have made the decision to self-inject subcutaneous DMPA (DMPA-SC) in the context of informed choice counseling. DMPA-SC is a lower-dose, easy-to-use injectable contraceptive that is administered every three months. The product’s user-friendly design means that any trained person can administer it, including community health workers, pharmacists, and even women themselves.